Literature DB >> 1356911

Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.

A Sjöstedt1, M Eriksson, G Sandström, A Tärnvik.   

Abstract

Tularaemia is an intracellular infection, which is controlled by the host as a result of an immunospecific T-cell response. A crucial product of the responding T cells is interferon-gamma (IFN-gamma), which acts by enhancing the microbicidal activity of macrophages. T cells of tularaemia-vaccinated individuals respond in vitro to a multitude of protein antigens of the vaccine strain Francisella tularensis LVS. In the present study, the responses to four of these antigens were shown to be confined mostly to the CD45RO+ memory T-cell subset. To characterize further the phenotype of the responding cells, purified CD4+ and CD8+ T cells were stimulated with the antigens. CD4+ T cells, but not CD8+ T cells, proliferated and produced IFN-gamma. However, when CD8+ T cells were isolated from bulk cultures of lymphocytes, which had been stimulated with antigen for 3 days, they responded to an extent similar to that of CD4+ T cells. Purified CD8+ T cells also responded when they were supplemented with interleukin-2 (IL-2). There was a direct quantitative correlation between the proliferative response of CD4+ and CD8+ T cells and their production of IFN-gamma. IL-2 was produced in the cultures, the amounts being higher in the cultures of CD4+ than in those of CD8+ cells. IL-4 was not detected in the culture medium of any of the T-cell subsets. Seventeen human alpha beta + CD4+ CD8- CD3+ T-cell clones, specific to antigens of F. tularensis, were raised. When proliferating, these clones did invariably produce IL-2 and IFN-gamma but no IL-4. In conclusion, both CD4+ and CD8+ T cells of tularaemia-vaccinated individuals respond with proliferation to various protein antigens of F. tularensis, and the proliferative response is strictly associated with IFN-gamma production. The CD8+ T-cell response seems to depend on cytokines supplied by proliferating CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356911      PMCID: PMC1421560     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

Review 1.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.

Authors:  A M Dannenberg
Journal:  Immunol Today       Date:  1991-07

2.  Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.

Authors:  M Merkenschlager; H Ikeda; D Wilkinson; P C Beverly; J Trowsdale; A G Fisher; D M Altmann
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

3.  Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce immunoglobulin production.

Authors:  H M Surcel; J Ilonen; K Poikonen; E Herva
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route.

Authors:  J J Neefjes; V Stollorz; P J Peters; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

5.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.

Authors:  G F Del Prete; M De Carli; C Mastromauro; R Biagiotti; D Macchia; P Falagiani; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Comparison of lymphokine secretion and responsiveness of human T cell clones isolated in IL-4 and in IL-2.

Authors:  X Paliard; J E de Vries; H Spits
Journal:  Cell Immunol       Date:  1991-07       Impact factor: 4.868

7.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

8.  Ability of pure resting CD8+ human T cells to respond to alloantigen.

Authors:  T Leivestad; R Halvorsen; G Gaudernack; E Thorsby
Journal:  Scand J Immunol       Date:  1989-05       Impact factor: 3.487

9.  Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation.

Authors:  C S Via; G C Tsokos; N I Stocks; M Clerici; G M Shearer
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

10.  Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen.

Authors:  Y Jin; W K Shih; I Berkower
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  19 in total

1.  Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis.

Authors:  Jason R Wickstrum; Kee-Jong Hong; Sirosh Bokhari; Natalie Reed; Nicholas McWilliams; Rebecca T Horvat; Michael J Parmely
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.

Authors:  Y Poquet; M Kroca; F Halary; S Stenmark; M A Peyrat; M Bonneville; J J Fournié; A Sjöstedt
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 3.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 4.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

5.  Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Authors:  Susan M Twine; Mireille D Petit; Kelly M Fulton; Robert V House; J Wayne Conlan
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

6.  Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.

Authors:  Hua Shen; Gregory Harris; Wangxue Chen; Anders Sjostedt; Patrik Ryden; Wayne Conlan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

Review 7.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

8.  Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.

Authors:  Raju Sunagar; Sudeep Kumar; Brian J Franz; Edmund J Gosselin
Journal:  Vaccine       Date:  2016-05-13       Impact factor: 3.641

9.  Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis.

Authors:  Jyotika Sharma; Qun Li; Bibhuti B Mishra; Michelle J Georges; Judy M Teale
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

10.  Cytokine expression in the liver during the early phase of murine tularemia.

Authors:  I Golovliov; G Sandström; M Ericsson; A Sjöstedt; A Tärnvik
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.